Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.

Simone NuessleClaudia Auw-HaedrichJana JiangDaniel BoehringerThomas Reinhard

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)

Topical IFN-α2b (arguably together with radiotherapy) may be a viable alternative to MMC in PAM and CM. We observed fewer side effects at similar response rates. However, when response to MMC was poor, IFN-α2b may also be of limited utility.

Keyphrases

dendritic cells
immune response
early stage
radiation therapy
electronic health record
squamous cell carcinoma